Abiopharma

🔍 EDGEMOND JAMES (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-06-08

Detailed Transactions and Holdings:

• Acquired 10,000 shares of Common Stock at $117.76 per share (Direct)
  Date: 2026-06-08 | Code: M | equity_swap_involved: false | shares_owned_after: 28,876.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,565 shares of Common Stock at $544.9334 per share (Direct)
  Date: 2026-06-08 | Code: S | equity_swap_involved: false | shares_owned_after: 27,311.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,989 shares of Common Stock at $546.1339 per share (Direct)
  Date: 2026-06-08 | Code: S | equity_swap_involved: false | shares_owned_after: 25,322.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 1,888 shares of Common Stock at $547.0292 per share (Direct)
  Date: 2026-06-08 | Code: S | equity_swap_involved: false | shares_owned_after: 23,434.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 2,158 shares of Common Stock at $547.9111 per share (Direct)
  Date: 2026-06-08 | Code: S | equity_swap_involved: false | shares_owned_after: 21,276.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 425 shares of Common Stock at $549.3819 per share (Direct)
  Date: 2026-06-08 | Code: S | equity_swap_involved: false | shares_owned_after: 20,851.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 1,285 shares of Common Stock at $550.0937 per share (Direct)
  Date: 2026-06-08 | Code: S | equity_swap_involved: false | shares_owned_after: 19,566.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 610 shares of Common Stock at $551.2826 per share (Direct)
  Date: 2026-06-08 | Code: S | equity_swap_involved: false | shares_owned_after: 18,956.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 80 shares of Common Stock at $551.755 per share (Direct)
  Date: 2026-06-08 | Code: S | equity_swap_involved: false | shares_owned_after: 18,876.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 10,000 shares of Stock Option at $117.76 per share (Derivative)
  Date: 2026-06-08 | Code: M | Expires: 2027-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 20,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.
• F2: This transaction was executed in multiple trades at prices ranging from $544.41 to $545.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: This transaction was executed in multiple trades at prices ranging from $545.47 to $546.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $546.51 to $547.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $547.52 to $548.485. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $548.59 to $549.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $549.59 to $550.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $550.63 to $551.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $551.74 to $551.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.